Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cody Palmer

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Viruses|August 29, 2024
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United StatesCody Palmer, Edith Morais, Joseph Tota
Mathematical Biosciences|January 18, 2018
The dynamics of vector-borne relapsing diseasesCody Palmer, Erin Landguth, Emily Stone, et al.
Expert Review of Vaccines|February 28, 2024
Cost-effectiveness of nonavalent HPV vaccination in the NetherlandsCody Palmer, Christiaan Dolk, Ugne Sabale, et al.
Journal of Medical Economics|June 18, 2025
Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling studyCody Palmer, Taizo Matsuki, Keisuke Tobe, et al.
Journal of Health Economics and Outcomes Research|July 7, 2022
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United KingdomKwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, et al.
JAMA Network Open|October 4, 2024
Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UKAlhaji Cherif, Olga Ovcinnikova, Cody Palmer, et al.
BMC Public Health|December 6, 2025
The public health impact of extending the catch-up nonavalent human papillomavirus vaccination program to 2028 in Japan: a model-based studyIbrahim Diakite, Keisuke Tobe, Xuedan You, et al.
Journal of Medical Economics|November 14, 2023
Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in JapanCody Palmer, Keisuke Tobe, Yusuke Negishi, et al.
Frontiers in Oncology|June 11, 2025
Strategies to accelerate cervical cancer elimination in Greece: a modeling studyCody Palmer, Anastasios Skroumpelos, Ugne Sabale, et al.
Human Vaccines & Immunotherapeutics|March 17, 2025
A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in ItalyAlhaji Cherif, Cody Palmer, Francesca Senese, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Viruses|August 29, 2024
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United StatesCody Palmer, Edith Morais, Joseph Tota
Mathematical Biosciences|January 18, 2018
The dynamics of vector-borne relapsing diseasesCody Palmer, Erin Landguth, Emily Stone, et al.
Expert Review of Vaccines|February 28, 2024
Cost-effectiveness of nonavalent HPV vaccination in the NetherlandsCody Palmer, Christiaan Dolk, Ugne Sabale, et al.
Journal of Medical Economics|June 18, 2025
Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling studyCody Palmer, Taizo Matsuki, Keisuke Tobe, et al.
Journal of Health Economics and Outcomes Research|July 7, 2022
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United KingdomKwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, et al.
JAMA Network Open|October 4, 2024
Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UKAlhaji Cherif, Olga Ovcinnikova, Cody Palmer, et al.
BMC Public Health|December 6, 2025
The public health impact of extending the catch-up nonavalent human papillomavirus vaccination program to 2028 in Japan: a model-based studyIbrahim Diakite, Keisuke Tobe, Xuedan You, et al.
Journal of Medical Economics|November 14, 2023
Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in JapanCody Palmer, Keisuke Tobe, Yusuke Negishi, et al.
Frontiers in Oncology|June 11, 2025
Strategies to accelerate cervical cancer elimination in Greece: a modeling studyCody Palmer, Anastasios Skroumpelos, Ugne Sabale, et al.
Human Vaccines & Immunotherapeutics|March 17, 2025
A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in ItalyAlhaji Cherif, Cody Palmer, Francesca Senese, et al.
Pageof 2